je.st
news
Tag: advanced
Trojan Battery launches Smart Carbon line of advanced lead acid batteries; improved performance at partial state of charge
2014-01-17 11:30:16| Green Car Congress
Northrop Grumman Unveils Advanced Pulse Generation Technology With Direct Digital Synthesis For Next Generation Advanced Threats
2014-01-16 07:23:48| rfglobalnet News Articles
Northrop Grumman Corporation (NYSE:NOC) has finished detailed performance testing on its Advanced Pulse Generator (APG), which represents the next technology evolution for the company's Combat Electromagnetic Environment Simulator (CEESIM) product that is used to test and validate the performance of electronic warfare equipment.
Tags: advanced
technology
digital
direct
01.16.14 -- VNA Advances Meet Challenges Of Advanced Radar Systems
2014-01-15 09:55:48| rfglobalnet Home Page
01/16/14 RF Globalnet Newsletter
Tags: advanced
systems
meet
challenges
EV Group Ships Temporary Bonding/Debonding System to Fraunhofer ISIT for Developing Advanced ...
2014-01-14 06:00:00| Industrial Newsroom - All News for Today
EVG® 850TB/DB product order follows multi-year process development cooperation in thin-wafer applications for PowerMOS and Insulated Gate Bipolar Transistor (IGBT) devices<br /> <br /> ST. FLORIAN, Austria – EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that the Fraunhofer Institute for Silicon Technology (ISIT) has purchased an EVG® 850TB/DB fully automated bonding/debonding equipment ...This story is related to the following:Machinery and Machining Tools Sponsored by: Haas Automation, Inc. - Category SponsorWafer Processing Systems | Bonding Machinery | Wafer Coating Equipment
Tags: system
group
advanced
ships
Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma
2014-01-13 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Expects to Complete Application in First Half of 2014 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has started a rolling submission to the U.S. Food and Drug Administration (FDA) of a Biologics License Application for MK-3475, the companys investigational anti-PD-1 immunotherapy, for patients with advanced melanoma who have been previously treated with ipilimumab. A rolling submission allows completed portions of the application to be submitted and reviewed by the FDA on an ongoing basis. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046Claire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-500-1101Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
advanced
application
license
Sites : [364] [365] [366] [367] [368] [369] [370] [371] [372] [373] [374] [375] [376] [377] [378] [379] [380] [381] [382] [383] next »